The HCPLive Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.
October 9th 2024
Remission according to the simplified definition correlated with the 2016 preliminary gout remission definition and GIS score improvements.
Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
October 26, 2024
Register Now!
6th Annual Advanced Practice Collaborative
View More
SimulatED™: Personalizing Treatment Choices to Achieve Glycemic and Weight Management Goals
View More
Cases and Conversations™: Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis
November 18, 2024
Register Now!
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
Gene Regulates Tissue Damage Severity in Rheumatoid Arthritis
August 31st 2015Early diagnosis continues to be one of the biggest challenges associated with rheumatoid arthritis (RA); however, researchers have identified a genetic marker that can predict tissue damage severity that could lead to better treatments.
Study: NSAIDs, COX-2 inhibitors Have Equivalent Side Effects
Researchers in Scotland found that in a trial involving more tha n 7,000 patients, the rates of adverse cardiac and other negative outcomes were about the same whether these patients took NSAIDs or COX-2 inhibitors.
Hypermobility Conditions Treatment Hampered Due to Lack of Clinical Understanding
Mobility is great. Hypermobility? Less great. In the joints, hypermobility leads to musculoskeletal pain – and often times, lots of it. A recent review in the Journal of Pain Research outlined several of the challenges in treating generalized joint hypermobility (GJH) and found many difficult questions and few easy answers.
Early Use of DMARDs Linked to Delayed Need for Joint Replacement Surgery
Study results suggest that longer exposure to methotrexate and other disease-modifying anti-rheumatic drugs within the first year of diagnosis is associated with a significantly longer time to joint replacement surgery.
Studies: Exercise and Sleep Are Key in Ankylosing Spondylitis
A recent study suggests that patients with ankylosing spondylitis (AS) have a higher incidence of obstructive sleep apnea syndrome that increases with the severity of cervical vertebral involvement. A separate study published on the same day suggests that specific exercise regimens may be beneficial for patients with AS.
Lack of Standardized Measurements Clouds Picture of Pain Interventions
Data concerning general outcomes and indicating performance of general pain clinics remain sparse, according to a study in the Journal of Pain and Research. The United Kingdom study suggests that this lack of standardized measurements negatively impacts the ability to judge the overall effectiveness of pain clinics, both in the UK and in other parts of the world.
Cluster Headache Remains an Enigma Despite Clinical Clues
A recent study in The Journal of Headache and Pain sheds some additional light on the chronobiological experience of patients with cluster headache (CH). However, it still leaves lingering mysteries around the pattern of pain CH that patients typically experience, the triggers of those headaches, and the mechanisms and interactions that drive headache frequency and severity.
RAPID3 Shown to Be an Effective Assessment Tool for Patients with Psoriatic Arthritis
New research suggests that a 10-second self assessment might provide nearly as much information about psoriatic arthritis case progression as complex tests that generally require either require laboratory results or formal joint-by-joint evaluation.
Increased Cardiovascular and Cerebrovascular Mortality in Ankylosing Spondylitis
August 18th 2015In one of the first large-scale studies designed to assess the risk of vascular mortality in patients with ankylosing spondylitis, researchers have found that patients with ankylosing spondylitis have a significantly higher risk for vascular death as compared to healthy populations.